全球生物防御市场（2023-2030）：规模、份额、成长分析以及按类型和应用分类的预测

全球生物防御市场规模将从2021年的142.7亿美元成长到2022年的150亿美元，预测期内年复合成长率为5.1%，预计到2030年将达到223.3亿美元。

近年来，由于生技药品的威胁日益增加以及对有效准备和应对措施的需求，全球生物防御市场经历了显着的成长和转型。生物防御是指旨在应对与生物恐怖主义、流行病和其他生物紧急情况相关的潜在风险的各种活动和技术，这个市场包括疫苗、治疗、检测和诊断、防护工具等多种领域。

人们对生物攻击和集体爆发造成的潜在灾难的认识不断增强，导致对生物防御解决方案的需求激增。世界各国政府正对生物防御能力进行大量投资，推动市场成长。此外，技术进步和对研发的日益关注也导致了创新和复杂的生物防御产品的推出。基因组学、合成生物学和资料分析等技术的进步增强了生物威胁的检测、表征和缓解能力，并推动了生物防御解决方案的发展。此外，政府、国防机构和私人企业之间的合作也促进了综合生物防御战略的发展并支持市场扩张。

该报告调查了全球生物防御市场，并提供了市场概况、市场各种影响因素分析、技术和创新趋势、法律制度、市场规模趋势和预测，以及按各个细分市场和地区进行的竞争。形势、主要企业简介等

目录

• 执行摘要
• 调查方法
• 母市场分析
  • 市场概况
  • 市场规模
  • 市场动态
    • 促进因素
    • 机会
    • 抑制因素
    • 任务
• 关键市场洞察
  • 技术分析
  • 价格分析
  • 供应链分析
  • 价值链分析
  • 市场生态系统
  • 智慧财产权分析
  • 贸易分析
  • 启动分析
  • 原料分析
  • 创新矩阵
  • 研发线产品分析
  • 总体经济指标
  • 重点投资分析
  • 关键成功因素
  • 竞争程度
  • 市场动态及展望
    • 市场动态
      • 促进因素
      • 机会
      • 抑制因素
      • 任务
  • 法规状况
  • 波特的分析
  • Skyquest 对未来颠覆的独家见解
• 全球生物防御市场：按类型
  • 市场概况
  • 炭疽菌
  • 天花
  • 肉毒中毒
  • 辐射/核能
  • 其他的
• 全球生物防御市场：依应用分类
  • 市场概况
  • 医院/诊所
  • 门诊治疗中心
  • 其他的
• 全球生物防御市场：按地区
  • 市场概况
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲
• 竞争形势
  • 前5名企业对比
  • 主要企业市场地位
  • 主要企业的招募策略
  • 关键成功策略
  • 近期市集活动
  • 主要企业市场占有率
• 主要企业简介
  • XOMA Corporation
  • Altimmune Inc.
  • Emergent Biosolutions Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies
  • Elusys Therapeutics Inc.
  • Ichor Medical Systems
  • Dynport Vaccine Company
  • Cleveland Biolabs
  • Bavarian Nordic
  • Ology Bioservices
  • Alnylam Pharmaceuticals Inc.
  • Evolva
  • BioCryst Pharmaceuticals Inc.
  • PharmAthene Inc.
  • Profectus Biosciences Inc.
  • NanoViricides Inc.
  • Takeda Pharmaceutical Company Limited
  • Sanofi Pasteur
  • GlaxoSmithKline

Global Biodefense Market size was valued at USD 14.27 billion in 2021 and is poised to grow from USD 15 billion in 2022 to USD 22.33 billion by 2030, growing at a CAGR of 5.1% during the forecast period (2023-2030).

The global biodefense market has witnessed significant growth and transformation in recent years, driven by the increasing threats posed by biological agents and the need for effective preparedness and response measures. Biodefense refers to a range of activities and technologies aimed at countering the potential risks associated with bioterrorism, pandemics, and other biological emergencies. The market encompasses various sectors, including vaccines, therapeutics, detection and diagnostics, and protective equipment. The demand for biodefense solutions has surged due to the growing recognition of the potential catastrophic consequences of biological attacks and outbreaks. Governments around the world are investing heavily in biodefense capabilities, bolstering the market's growth. Additionally, advancements in technology and the increasing focus on research and development have led to the introduction of innovative and sophisticated biodefense products. Technological advancements, including genomics, synthetic biology, and data analytics, are driving the evolution of biodefense solutions, providing enhanced capabilities in detection, characterization, and mitigation of biological threats. Furthermore, collaborations between governments, defense agencies, and private sector entities have fostered the development of comprehensive biodefense strategies and bolstered market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Biodefense Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Biodefense Market Segmental Analysis

Global Biodefense Market is segmented by type, application, and region. Based on type, the market can be segmented into Anthrax, Smallpox, Botulism, Radiation/Nuclear and Others. Based on application, the market is segmented into Hospitals and clinics, ambulatory care centres and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Biodefense Market Dynamics

Drivers of the Global Biodefense Market

Increasing recognition of the potential catastrophic consequences of biological threats

One key driver of the global biodefense market is the increasing recognition of the potential catastrophic consequences of biological threats. Governments, defense agencies, and healthcare organizations worldwide are investing heavily in biodefense capabilities to mitigate the risks posed by bioterrorism, pandemics, and other biological emergencies.

Restraints in the Global Biodefense Market

High costs associated with research and development of biodefense solutions

A notable restraint for the Global Biodefense Market is the high costs associated with research and development of biodefense solutions. Developing effective vaccines, therapeutics, and detection systems requires substantial investment in research, clinical trials, and regulatory approvals. The complex nature of biodefense threats adds to the challenges, making it difficult to achieve cost-effective solutions and hindering market growth.

Market Trends of the Global Biodefense Key

One key market trend in the global biodefense market is the increasing focus on the development of advanced diagnostic technologies. There is a growing emphasis on the rapid and accurate detection of biological agents to enable early intervention and effective response during biodefense incidents. Innovative diagnostic tools, such as point-of-care testing devices and molecular diagnostics, are being developed to enhance the speed and accuracy of identifying potential biological threats. This trend aims to strengthen surveillance systems and improve the overall preparedness and response capabilities in biodefense scenarios.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Biodefense Market by Type
  • Market Overview
  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/Nuclear and Others
• Global Biodefense Market by Application
  • Market Overview
  • Hospitals and clinics
  • ambulatory care centres and others
• Global Biodefense Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • XOMA Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Altimmune Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Emergent Biosolutions Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Dynavax Technologies Corporation (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • SIGA Technologies (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Elusys Therapeutics Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ichor Medical Systems (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Dynport Vaccine Company (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Cleveland Biolabs (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Bavarian Nordic (Denmark)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Ology Bioservices (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Alnylam Pharmaceuticals Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Evolva (Switzerland)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • BioCryst Pharmaceuticals Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PharmAthene Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Profectus Biosciences Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • NanoViricides Inc. (US)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Takeda Pharmaceutical Company Limited (Japan)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Sanofi Pasteur (France)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • GlaxoSmithKline (UK)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments